These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8836893)

  • 1. New and forthcoming therapies for viral hepatitis.
    Carreño V; Quiroga JA
    J Hepatol; 1996; 24(2 Suppl):74-6. PubMed ID: 8836893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic response modifiers in chronic hepatitis C.
    Carreño V; Quiroga JA
    J Hepatol; 1995; 22(1 Suppl):122-6. PubMed ID: 7541408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M; Golstein P; Botembe N; Bourgeois N
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel treatment of patients with chronic hepatitis C.
    Tsai NC; Shimoda N; Wong L; Shimoda S; Goad K; Yee H; Chen M
    Hawaii Med J; 1999 Apr; 58(4):85-8. PubMed ID: 10363429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B and C: current therapy].
    Bruch HR; Höhner U; Müller R
    Praxis (Bern 1994); 1998 Oct; 87(42):1408-12. PubMed ID: 9824948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon-alpha in the treatment of chronic viral hepatitis].
    Melman ML
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):46-8. PubMed ID: 8091094
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Tokushige K; Wands JR
    J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 14. Extrahepatic manifestations of chronic viral hepatitis.
    Willson RA
    Am J Gastroenterol; 1997 Jan; 92(1):3-17. PubMed ID: 8995930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interferon alpha and chronic viral hepatitis].
    Ouzan D
    Rev Prat; 1994 Sep; 44(13):1714-8. PubMed ID: 7939251
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Williams R
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous side effects of clinically relevant cytokine therapies].
    Trefzer U; Hofmann M; Sterry W
    Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1782-7. PubMed ID: 12934174
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon and other therapies for hepatitis B and hepatitis C infections.
    Rothstein KD; Munoz SJ
    Clin Lab Med; 1996 Jun; 16(2):465-91. PubMed ID: 8792083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuncts to antibacterial therapy.
    Frank MO; Mandell GL
    Infect Dis Clin North Am; 1995 Sep; 9(3):769-81. PubMed ID: 7490443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000.
    Meyers FJ; O' Donnell RT
    Clin Cancer Res; 2000 Oct; 6(10):4167. PubMed ID: 11051273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.